UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis

Thrombosis and haemostasis, 2020-02, Vol.120 (2), p.243-252

2020

Volltextzugriff (PDF)

Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes

Chemical science (Cambridge), 2021-02, Vol.12 (11), p.479-493

2021

Volltextzugriff (PDF)

Abstract 1719: A Potential Mechanism for the Reduced Efficacy of Aspirin in Individuals with Diabetes

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation

PloS one, 2012-04, Vol.7 (4), p.e35690

2012

Volltextzugriff (PDF)

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Cardiovascular diabetology, 2020-01, Vol.19 (1), p.3-13, Article 3

2020

Volltextzugriff (PDF)

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes

Diabetes care, 2018-12, Vol.41 (12), p.2625-2633

2018

Volltextzugriff (PDF)

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Blood, 2019-03, Vol.133 (11), p.1233-1244

2019

Volltextzugriff (PDF)

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Arteriosclerosis, thrombosis, and vascular biology, 2015-12, Vol.35 (12), p.2562

2015

Volltextzugriff (PDF)

Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity

Journal of molecular endocrinology, 2008-04, Vol.40 (4), p.173-184

2008

Volltextzugriff (PDF)

Affinity purification of fibrinogen using an Affimer column

Biochimica et biophysica acta. General subjects, 2022-05, Vol.1866 (5), p.130115-130115, Article 130115

2022

Volltextzugriff (PDF)

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2024-06, Vol.17 (11), p.1356-1370

2024

Volltextzugriff (PDF)

Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications

European journal of endocrinology, 2020-05, Vol.182 (5), p.511-521

2020

Volltextzugriff (PDF)

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

JACC. Cardiovascular interventions, 2024-06, Vol.17 (11), p.1356

2024

Volltextzugriff (PDF)

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

Thrombosis and haemostasis, 2014-12, Vol.112 (6), p.1142-1150

2014

Volltextzugriff (PDF)

Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery

Research and practice in thrombosis and haemostasis, 2024-02, Vol.8 (2), p.102361-102361, Article 102361

2024

Volltextzugriff (PDF)

Gender-Specific Alterations in Fibrin Structure Function in Type 2 Diabetes: Associations with Cardiometabolic and Vascular Markers

The journal of clinical endocrinology and metabolism, 2012-12, Vol.97 (12), p.E2282-E2287

2012

Volltextzugriff (PDF)

203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A112-A112

2015

Volltextzugriff (PDF)

203Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A112-A112

2015

Volltextzugriff (PDF)

Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study

Thrombosis and haemostasis, 2016-03, Vol.115 (3), p.622-631

2016

Volltextzugriff (PDF)

Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis

Blood advances, 2024-11

2024

Volltextzugriff (PDF)

P2Y 12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study

JACC. Cardiovascular interventions, 2024-06, Vol.17 (11), p.1356

2024

Volltextzugriff (PDF)

Potential mechanism for increased risk of premature vascular disease in long-term survivors of primary brain tumours with established hormone deficits

The Lancet (British edition), 2017-02, Vol.389, p.S57-S57

2017

Volltextzugriff (PDF)

SUN-085 Assessing the Impact of Disease Activity on Clot Formation and Lysis in Patients with Acromegaly

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Volltextzugriff (PDF)

SUN-075 Higher Fibrinogen and Clot Density in Patients with Acromegaly: The Role of Adverse Body Composition to the Increased Thrombotic Potential

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Volltextzugriff (PDF)

Platelet P2Y 12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Arteriosclerosis, thrombosis, and vascular biology, 2015-12, Vol.35 (12), p.2562-2570

2015

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis

Albumin-mediated alteration of plasma zinc speciation by fatty acids modulates blood clotting in type-2 diabetes

Abstract 1719: A Potential Mechanism for the Reduced Efficacy of Aspirin in Individuals with Diabetes

Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity

Affinity purification of fibrinogen using an Affimer column

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention

Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery

Gender-Specific Alterations in Fibrin Structure Function in Type 2 Diabetes: Associations with Cardiometabolic and Vascular Markers

203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia

203Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia

Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study

Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis

P2Y 12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study

Potential mechanism for increased risk of premature vascular disease in long-term survivors of primary brain tumours with established hormone deficits

SUN-085 Assessing the Impact of Disease Activity on Clot Formation and Lysis in Patients with Acromegaly

SUN-075 Higher Fibrinogen and Clot Density in Patients with Acromegaly: The Role of Adverse Body Composition to the Increased Thrombotic Potential

Platelet P2Y 12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Suchergebnisse filtern